Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India

Back Stocks profile

Stock analysis tool for investors

Caplin Point Laboratories Ltd.

NSE: CAPLIPOINT | BSE:524742

₹1429.50 -20.50 (-1.41%) 1D

Pharmaceuticals & Biotechnology

Buy Sell
View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

1423.70

Today’s High

1458.00

52W low

783.00

52W High

1619.00

Open Price

1451.00

Prev. Close

1303.5500

Volume

154470.00

Value

220814865.00

Fundamentals

Market Cap Cr

10865.70

Price to Earnings

23.80

Price to Book Value

4.60

Dividend Yield

0.30

PE to Growth

1.10

Op Revenue TTM Cr

1694.10

Net Profit TTM Cr

457.10

Cash From Operating Activity Cr

310.98

Return on Equity %

19.73

EMA & SMA

Bullish Moving Averages

12

Bearish Moving Averages

4

5Day EMA

1447

10Day EMA

1433

12Day EMA

1427.4

20Day EMA

1407.2

26Day EMA

1395.6

50Day EMA

1371.6

100Day EMA

1347.4

200Day EMA

1265.7

5Day SMA

1446.7

10Day SMA

1430.3

20Day SMA

1403.8

30Day SMA

1367.7

50Day SMA

1350.9

100Day SMA

1368.8

150Day SMA

1364.4

200Day SMA

1294.3

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

02 Jul, 2024

58.1

Week

40.6

Month

42.4

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

1458.65

PIVOT

First Resistance

1470.30

Second Resistance

1490.60

Third Resistance

1502.25

First Support

1438.35

Second Support

1426.70

Third Support

1406.40

Relative Strength Index

59.33

Money Flow Index

50.39

MACD

31.8

MACD Signal

28.32

Average True Range

49.77

Average Directional Index

25.65

Rate of Change (21)

12.38

Rate of Change (125)

6.92

Commodity Channel Index

76.3

Williams %R

-43.5

BETA

1 Month

0.64

3 Month

0.7

1 Year

0.4

3 Year

0.38

PRICE CHANGE ANALYSIS

↑ 1.92%

1 Week

Low

High

1365

1515.4

↑ 10.79%

1 Month

Low

High

1225

1543.1

↑ 8.88%

3 Months

Low

High

1225

1543.1

↑ 2.55%

6 Months

Low

High

1225

1619.05

↑ 77.24%

1 Year

Low

High

783.05

1619.05

Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 175.56 150.73 203.71 200.93 156.89 159.96 159.40 151.36 122.20 136.76 178.82
Operating Expenses Qtr 81.70 69.51 89.77 97.04 79.80 79.09 79.53 70.28 73.53 74.74 89.00
Operating Profit Qtr 57.68 63.32 89.45 76.62 64.87 51.51 57.42 46.11 38.41 53.48 71.40
EBIDT Qtr Cr 93.86 81.22 113.94 103.89 77.09 80.87 79.87 81.08 48.67 62.02 89.82
Depreciation Qtr 6.93 6.76 6.72 6.67 6.29 6.47 6.51 6.37 6.95 6.31 6.31
Net Profit Qtr 69.88 55.45 82.09 76.27 54.33 59.17 57.51 63.24 29.02 39.12 65.16
Basic EPS Qtr 9.20 7.30 10.82 10.04 7.15 7.80 7.59 8.34 3.83 5.17 8.61
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 730.93 627.61 584.61 501.30 593.80
Operating Expenses Annual Cr 338.01 308.69 308.44 268.75 320.83
Operating Profit Annual 287.08 219.92 219.62 213.92 206.99
Operating Profit Margin Annual % 39.28 35.04 37.57 42.67 34.86
Total Expenses Annual Cr 365.19 334.46 334.30 291.36 340.67
EBIDT Annual Cr 392.92 318.92 276.17 232.54 272.96
EBIDT Annual margin % 53.76 50.81 47.24 46.39 45.97
Depreciation 27.08 25.65 25.77 22.44 19.65
PAT Before ExtraOrdinary Items Annual Cr 283.71 234.26 187.87 156.22 197.64
Net Profit Annual 283.71 234.26 187.87 156.22 197.64
Basic EPS Annual 37.36 30.89 24.82 20.65 26.13
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 1390.15 1139.91 930.65 758.67 599.91
Minority Interest Liability Annual Cr - - - - -
Total Non Current Liabilities Annual Cr 12.86 16.42 24.63 25.00 27.16
Total Current Liabilities Annual Cr 119.30 146.85 98.88 77.33 64.26
Total Capital Plus Liabilities Annual Cr 1522.31 1303.18 1054.16 861.00 691.33
Fixed Assets Annual 192.69 199.53 165.06 184.05 170.70
Total Non Current Assets Annual 819.81 639.20 448.49 328.35 310.59
Total Current Assets Annual 702.50 663.98 605.67 532.65 380.74
Total Assets Annual 1522.31 1303.18 1054.16 861.00 691.33
Contingent Liabilities plus Commitments Annual Cr - 84.60 36.81 44.61 26.56
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 104.21 157.10 230.97 294.65 87.01
Cash from Investing Activity Annual -112.14 -86.67 -237.18 16.28 -41.06
Cash from Financing Annual Activity -34.26 -30.42 -22.76 -3.46 -32.92
Net Cash Flow Annual - 40.01 -28.97 307.46 13.03
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 183.03 150.19 122.78 100.30 79.31
ROE Annual % 20.40 20.55 20.18 20.59 32.94
ROCE Annual % 26.07 25.36 26.21 26.81 40.39
Total Debt to Total Equity Annual 0.00 0.00 0.00 0.00 0.00
EBDIT Annual Margin % 62.85 60.33 52.29 48.17 51.71
Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 470.51 452.68 430.49 407.36 400.68 386.22 375.53 360.27 350.75 335.74 312.02
Operating Expenses Qtr 307.99 293.22 272.66 268.79 265.35 262.70 253.47 244.15 239.30 225.24 202.36
Operating Profit Qtr 145.23 142.28 137.40 126.53 123.93 109.37 105.58 102.18 99.94 100.96 101.17
EBIDT Qtr Cr 162.52 159.46 157.83 138.57 135.33 123.52 122.06 116.12 111.45 110.50 109.66
Depreciation Qtr 16.40 13.90 11.76 11.38 11.13 11.43 11.46 10.97 11.45 11.70 11.72
Net Profit Qtr 121.59 117.20 114.88 103.43 102.11 97.48 91.67 84.99 79.06 74.95 74.98
Basic EPS Qtr 16.01 15.44 15.13 13.62 13.45 12.86 12.09 11.21 10.43 9.90 9.91
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 1761.04 1522.71 1308.16 1084.83 904.54
Operating Expenses Annual Cr 1142.66 1025.67 874.74 732.65 603.13
Operating Profit Annual 551.44 441.06 394.67 328.64 260.07
Operating Profit Margin Annual % 31.31 28.97 30.17 30.29 28.75
Total Expenses Annual Cr 1196.88 1071.44 922.34 771.21 635.07
EBIDT Annual Cr 618.38 497.04 433.42 352.18 301.40
EBIDT Annual margin % 35.11 32.64 33.13 32.46 33.32
Depreciation 53.44 44.99 46.90 36.97 31.62
PAT Before ExtraOrdinary Items Annual Cr 461.15 376.99 308.45 251.43 215.08
Net Profit Annual 457.09 376.26 299.84 242.27 215.01
Basic EPS Annual 59.90 49.18 39.61 31.71 28.20
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 2315.70 1805.90 1409.35 1185.82 873.33
Minority Interest Liability Annual Cr 31.12 26.79 25.95 17.54 8.66
Total Non Current Liabilities Annual Cr 20.00 16.13 18.76 17.39 24.86
Total Current Liabilities Annual Cr 330.55 268.00 207.68 142.85 144.32
Total Capital Plus Liabilities Annual Cr 2697.37 2191.40 1736.32 1363.61 1125.76
Fixed Assets Annual 567.76 500.52 304.30 319.22 292.62
Total Non Current Assets Annual 805.16 636.94 438.50 327.80 303.23
Total Current Assets Annual 1892.21 1554.46 1297.82 1035.81 822.53
Total Assets Annual 2697.37 2191.40 1736.32 1363.61 1125.76
Contingent Liabilities plus Commitments Annual Cr - 257.94 124.66 62.15 51.99
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 310.98 271.37 336.75 265.77 44.68
Cash from Investing Activity Annual -312.63 -217.58 -270.94 -5.36 -54.50
Cash from Financing Annual Activity -38.07 -28.17 -40.71 -23.98 79.77
Net Cash Flow Annual - 25.62 25.10 236.44 69.94
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 309.00 241.46 189.35 159.08 116.60
ROE Annual % 19.73 20.83 21.27 20.43 24.61
ROCE Annual % 23.86 23.50 25.28 25.82 27.48
Total Debt to Total Equity Annual 0.00 0.00 0.00 0.01 0.04
EBDIT Annual Margin % 36.50 33.88 34.14 33.18 34.91
Name Holding Percent Holding Id Pledged % Locked %
SURESH KUMAR AGARWAL 1.32 75045108 - -
Name Holding Percent Holding Id Pledged % Locked %
P VIJAYALAKSHMI 24.73 75045082 0 0
PAARTHIPAN C C 18.66 75045083 0 0
ASHOK GORKEY PARTHEEBAN 11.92 75045084 0 0
PARTHEEBAN VIVEK SIDDARTH 11.85 75045085 0 0
MAY INDIA PROPERTY PRIVATE LIMITED 2.79 75045087 0 0
Name Holding Percent Holding Id
Name Holding Percent Holding Id
SURESH KUMAR AGARWAL 1.32 75045108
Unclaimed or Suspense or Escrow Account 0.53 75045101
INVESTOR EDUCATION AND PROTECTION FUND AUTHORITY MINISTRY OF CORPORATE AFFAIRS 2.72 75045112
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
May 31, 2024 2.5 INTERIM May 31, 2024 Equity Share
Sep 14, 2023 2.5 FINAL - Equity Share
Jun 09, 2023 2 INTERIM Jun 09, 2023 Equity Share
Sep 21, 2022 2 FINAL - Equity Share
May 23, 2022 2 INTERIM May 24, 2022 Equity Share
Sep 20, 2021 1.5 FINAL - Equity Share
May 18, 2021 1.5 INTERIM May 19, 2021 Equity Share
Sep 21, 2020 0.4 FINAL - Equity Share
Mar 12, 2020 2.1 INTERIM Mar 13, 2020 Equity Share
Sep 04, 2019 2.2 FINAL - Equity Share
Sep 18, 2018 2 FINAL - Equity Share
Sep 07, 2017 1.5 FINAL - Equity Share
Sep 01, 2016 3.5 FINAL - Equity Share
Feb 15, 2016 2.5 INTERIM Feb 16, 2016 Equity Share
Oct 29, 2015 5 FINAL - Equity Share
Dec 11, 2014 4 FINAL - Equity Share
Dec 19, 2013 2.5 FINAL - Equity Share
Dec 11, 2012 2 FINAL - Equity Share
Dec 12, 2011 1.5 FINAL - Equity Share
Dec 09, 2010 1 FINAL - Equity Share
Sep 03, 2002 - FINAL - Equity Share
Ex-Date Split Ratio Record Date
Oct 19, 2016 10:2 2016-10-20
Ex-Date Purpose Notes
May 16, 2024 Audited Results & Interim Dividend -
Feb 09, 2024 Quarterly Results -
Nov 09, 2023 Quarterly Results -
Aug 07, 2023 Quarterly Results, Final Dividend & A.G.M. -
May 27, 2023 Audited Results & Interim Dividend (Revised)
Feb 11, 2023 Quarterly Results -
Nov 12, 2022 Quarterly Results -
Aug 05, 2022 Quarterly Results & Final Dividend -
May 12, 2022 Audited Results & Interim Dividend -
Feb 03, 2022 Quarterly Results -
Nov 02, 2021 Quarterly Results -
Aug 05, 2021 Quarterly Results & Final Dividend -
May 06, 2021 Audited Results & Interim Dividend -
Feb 04, 2021 Quarterly Results -
Nov 05, 2020 Quarterly Results -
Aug 10, 2020 Quarterly Results -
Jun 18, 2020 Audited Results & Final Dividend -
Mar 04, 2020 Interim Dividend -
Feb 05, 2020 Quarterly Results -
Oct 30, 2019 Quarterly Results -
Aug 12, 2019 Quarterly Results -
May 22, 2019 Audited Results & Final Dividend -
Feb 11, 2019 Quarterly Results -
Jan 18, 2019 Others To consider and approve the Investment by a global financial investor with strong healthcare experience in the Wholly Owned Subsidiary Company, Caplin Steriles Ltd.
Jan 11, 2019 Others -
Nov 19, 2018 Others -
Nov 02, 2018 Quarterly Results -
Aug 06, 2018 Quarterly Results -
May 28, 2018 Audited Results & Dividend -
Mar 12, 2018 Others To explore potential opportunities for attracting investments and / or know-how.
Feb 07, 2018 Quarterly Results -
Nov 09, 2017 Quarterly Results -
Aug 07, 2017 Quarterly Results -
May 10, 2017 Audited Results & Dividend -
Feb 06, 2017 Quarterly Results -
Nov 09, 2016 Quarterly Results Appointed Mr. D Sathyanarayanan as an Additional Director (Non-Executive - Independent) with effect from November 09, 2016.
Aug 05, 2016 Quarterly Results & Stock split -
May 27, 2016 Audited Results & Final Dividend -
Feb 05, 2016 Quarterly Results & Interim Dividend -
Nov 05, 2015 Quarterly Results -
Aug 20, 2015 Audited Results & Dividend -
May 12, 2015 Quarterly Results 1. Resignation of Mr. Venkat Radhakrishnan Mr. Venkat Radhakrishnan of the company. 2. Appointment of Mr. R Viswanathan as an Additional Director of comp.
Feb 04, 2015 Quarterly Results -
Nov 12, 2014 Quarterly Results -
Aug 25, 2014 Audited Results & Dividend -
May 12, 2014 Quarterly Results -
Feb 12, 2014 Quarterly Results -
Nov 07, 2013 Quarterly Results -
Aug 16, 2013 Audited Results & Final Dividend -
May 09, 2013 Quarterly Results -
Feb 13, 2013 Quarterly Results -
Nov 09, 2012 Audited, Dividend & Quarterly Results -
Aug 14, 2012 Quarterly Results -
May 12, 2012 Quarterly Results -
Feb 14, 2012 Quarterly Results -
Nov 21, 2011 Audited Results & Dividend -
Oct 31, 2011 Quarterly Results -
Jan 31, 2011 Quarterly Results -
Nov 22, 2010 Audited Results & Dividend To fix the record date/book closure dates to ascertain the members of the Co. for payment of Dividend, if any, for the year 2009-10 & to consider change of Registrar & Share Transfer Agents of the Co.
Oct 30, 2010 Quarterly Results -
Jul 31, 2010 Quarterly Results -
Apr 30, 2010 Quarterly Results -
Jan 30, 2010 Quarterly Results -
Nov 25, 2009 Audited Results -
Oct 31, 2009 Quarterly Results -
Jul 31, 2009 Quarterly Results -
Apr 30, 2009 Quarterly Results -
Jan 31, 2009 Quarterly Results -
Nov 24, 2008 Audited Results Fifteen Months
Oct 31, 2008 Quarterly Results -
Oct 13, 2008 Scheme of Amalgamation To take record on order of scheme of Amalgamation of Malind Laboratories Pvt. Ltd with Caplin Point Laboratories Ltd with effect from April 01, 2007.
Jul 31, 2008 Quarterly Results -
Apr 30, 2008 Amalgamation -
Mar 29, 2008 Extension of accounting year To extend the accounting year 2007-2008 up to June 30, 2008, due to administrative reasons.
Jan 31, 2008 Quarterly Results -
Oct 31, 2007 Quarterly Results -
Apr 30, 2007 Quarterly Results -
Mar 30, 2007 To close the current year accounts To close the current year accounts by March 31, 2007 and accordingly the accounts will be for a period of 9 months ending March 31, 2007.
Feb 24, 2007 Accounts -
Feb 05, 2007 To finalise the book closure -
Jan 31, 2007 Quarterly Results -
Oct 31, 2006 Quarterly Results -
Jul 27, 2006 Quarterly Results -
Apr 15, 2006 Quarterly Results & Amalgamation To consider the Scheme of Amalgamation in terms of which May (India) Laboratories Pvt Ltd will be amalgamated with the Company.
Nov 29, 2005 Accounts (15 months) -
Oct 28, 2005 Quarterly Results -
Jul 29, 2005 Quarterly Results -
Apr 30, 2005 Quarterly Results -
Mar 28, 2005 change of the Accounting year Decidedto change of the Accounting year of the Company from March ending to June ending i.e. Accounting Year 2004-05 will be of fifteen months and will end on June 30, 2005.
Jan 31, 2005 Quarterly Results -
Oct 30, 2004 Quarterly Results -
Aug 30, 2004 Accounts -
Jul 30, 2004 Quarterly Results -
Apr 29, 2004 Quarterly Results -
Jan 31, 2004 Quarterly Results -
Oct 30, 2003 Quarterly Results -
Aug 30, 2003 Accounts -
Jul 30, 2003 Quarterly Results -
Apr 30, 2003 Quarterly Results -
Jan 31, 2003 Quarterly Results -
Oct 31, 2002 Quarterly Results -
Jul 31, 2002 Quarterly Results -
Apr 30, 2002 Quarterly Results -
Jan 31, 2002 Quarterly Results -
Oct 31, 2001 Quarterly Results -
Aug 28, 2001 Accounts -
Jul 31, 2001 Quarterly Results -
Apr 30, 2001 Quarterly Results -
Jan 31, 2001 Quarterly Results -
Oct 31, 2000 Quarterly Results -
Sep 02, 2000 Accounts 18 months
Jul 31, 2000 Quarterly Results -
Apr 29, 2000 Quarterly Results -
Jan 31, 2000 Quarterly Results -
Oct 30, 1999 Quarterly Results -
Jul 30, 1999 Quarterly Results -
Apr 30, 1999 Quarterly Results -
Mar 04, 1999 Accounts -
Feb 10, 1999 To fix BC Dates. -
Jan 28, 1999 Quarterly Results -
Oct 21, 1998 Quarterly Results -
Jul 29, 1998 Quarterly Results -
May 29, 1998 Half Yearly Results -
Feb 14, 1998 Accounts -
Nov 29, 1997 Half Yearly Results -
May 30, 1997 Half Yearly Results -
Ex-Date Bonus Ratio Record Date
Bigul
27 Jun 2024

CAPLIN POINT LABORATORIES LTD. - 524742 - Closure of Trading Window

 Closure of Trading Window
Bigul
24 Jun 2024

CAPLIN POINT LABORATORIES LTD. - 524742 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Details of Loss of share certificate is attached.
Bigul
19 Jun 2024

CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Allotment

 The details of allotment of equity shares upon the exercise of stock options under various Employees Stock Option Schemes is attached herewith
Bigul
11 Jun 2024

CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Change in Management

 Details of appointment of SMP is enclosed herewith
Bigul
31 May 2024

CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Attached the Newspaper Ad relating to transfer of unclaimed dividend amount and equity shares of the company to the IEPF Account.
Bigul
29 May 2024

CAPLIN POINT LABORATORIES LTD. - 524742 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Pursuant to regulation 24(A) of SEBI Listing Regulations, the Annual Secretarial Compliance Report for the year ended March 31, 2024 is enclosed herewith
Bigul
24 May 2024

CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Press Release for Grant of USFDA Approval
Bigul
23 May 2024

CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

 Transcript of the Earnings Call held on May 16, 2024 is enclosed.
Bigul
17 May 2024

CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Newspaper Advertisement w.r.t financial results for the quarter and year ended 31.03.2024 in Financial Express (English Newspaper) and Maalai Malar (Tamil Newspaper) are attached.
Bigul
16 May 2024

CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 The weblink for the Earnings Call is enclosed herewith
See all News

FAQs

The latest market price of Caplin Point Laboratories Ltd. on NSE was Rs. 1429.50 as of today.

The opening share price of Caplin Point Laboratories Ltd. was Rs. 1451.00 as of today.

The 52-week high share price of Caplin Point Laboratories Ltd. was Rs. 1619.00.

The 52 week low share price of Caplin Point Laboratories Ltd. was Rs. 783.00.

Caplin Point Laboratories Ltd. has a market cap of Rs. 10865.70 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Caplin Point Laboratories Ltd. is 1.10. Please refer to the Fundamentals section for further details.

The operating revenue for Caplin Point Laboratories Ltd. in the last FY was Rs.  1694.10 crore. Please refer to the Financials section for further details.

The Net Profit for Caplin Point Laboratories Ltd. in the last FY was Rs. 457.10 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Caplin Point Laboratories Ltd. was on 2024-05-31 for Rs. 2.5 per share. According to today’s share price, the dividend yield of Caplin Point Laboratories Ltd. stands at 0.30. Please refer to the Corporate Actions section for further details.

Please find Corporate actions section for more details.

The latest split issue declared by Caplin Point Laboratories Ltd. was as of 2016-10-19. The split ratio declared in this issue was 10:2. Please refer to the Corporate Actions section for further details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Caplin Point Laboratories Ltd..

Close

Let's Open Free Demat Account